CIK: 0001388325 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 14, 2018
Total Value ($000): $713,357 (99.0% shares, 1.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INGN | INOGEN INC | 3,549,320 | $422,653 | 59.2% | $17.78 | +519.2% | COM | 45780L104 |
| — | ACCELERON PHARMA INC | 1,553,937 | $65,949 | 9.2% | $27.65 | — | COM | 00434H108 |
| — | DERMIRA INC | 1,984,364 | $55,185 | 7.7% | $30.14 | — | COM | 24983L104 |
| CRVS | CORVUS PHARMACEUTICALS INC | 3,244,046 | $33,608 | 4.7% | $14.33 | -10.6% | COM | 221015100 |
| AKBA | AKEBIA THERAPEUTICS INC | 2,225,000 | $33,086 | 4.6% | $11.69 | +41.9% | COM | 00972D105 |
| — | MERUS N V | 1,410,417 | $27,362 | 3.8% | $7.99 | — | COM | N5749R100 |
| — | NABRIVA THERAPEUTICS PLC | 2,924,822 | $17,490 | 2.5% | $10.02 | — | SHS | G63637105 |
| — | RA PHARMACEUTICALS INC | 2,031,562 | $17,268 | 2.4% | $15.19 | — | COM | 74933V108 |
| — | VERONA PHARMA PLC | 740,740 | $8,793 | 1.2% | $11.66 | — | SPONSORED ADS | 925050106 |
| — | INVUITY INC | 1,363,848 | $8,456 | 1.2% | $9.51 | — | COM NEW | 46187J205 |
| KIDS | ORTHOPEDIATRICS INC | 379,014 | $7,273 | 1.0% | $19.13 | 0.0% | COM | 68752L100 |
| — | WRIGHT MED GROUP N V | 4,622,032 | $6,979 | 1.0% | $1.25 | — | RIGHT 03/01/2019 | N96617126 |
| CRSP | CRISPR THERAPEUTICS AG | 223,317 | $5,243 | 0.7% | $18.69 | +1.7% | NAMEN AKT | H17182108 |
| GKOS | GLAUKOS CORP | 156,429 | $4,012 | 0.6% | $29.76 | 0.0% | COM | 377322102 |